Cargando…
Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479907/ https://www.ncbi.nlm.nih.gov/pubmed/37329568 http://dx.doi.org/10.1093/neuonc/noad095 |
| _version_ | 1785101692971253760 |
|---|---|
| author | Kocakavuk, Emre Johnson, Kevin C Sabedot, Thais S Reinhardt, Hans Christian Noushmehr, Houtan Verhaak, Roel G W |
| author_facet | Kocakavuk, Emre Johnson, Kevin C Sabedot, Thais S Reinhardt, Hans Christian Noushmehr, Houtan Verhaak, Roel G W |
| author_sort | Kocakavuk, Emre |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10479907 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104799072023-09-06 Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas Kocakavuk, Emre Johnson, Kevin C Sabedot, Thais S Reinhardt, Hans Christian Noushmehr, Houtan Verhaak, Roel G W Neuro Oncol Letter to the Editor Oxford University Press 2023-06-17 /pmc/articles/PMC10479907/ /pubmed/37329568 http://dx.doi.org/10.1093/neuonc/noad095 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Letter to the Editor Kocakavuk, Emre Johnson, Kevin C Sabedot, Thais S Reinhardt, Hans Christian Noushmehr, Houtan Verhaak, Roel G W Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas |
| title | Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas |
| title_full | Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas |
| title_fullStr | Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas |
| title_full_unstemmed | Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas |
| title_short | Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas |
| title_sort | hemizygous cdkn2a deletion confers worse survival outcomes in idhmut-noncodel gliomas |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479907/ https://www.ncbi.nlm.nih.gov/pubmed/37329568 http://dx.doi.org/10.1093/neuonc/noad095 |
| work_keys_str_mv | AT kocakavukemre hemizygouscdkn2adeletionconfersworsesurvivaloutcomesinidhmutnoncodelgliomas AT johnsonkevinc hemizygouscdkn2adeletionconfersworsesurvivaloutcomesinidhmutnoncodelgliomas AT sabedotthaiss hemizygouscdkn2adeletionconfersworsesurvivaloutcomesinidhmutnoncodelgliomas AT reinhardthanschristian hemizygouscdkn2adeletionconfersworsesurvivaloutcomesinidhmutnoncodelgliomas AT noushmehrhoutan hemizygouscdkn2adeletionconfersworsesurvivaloutcomesinidhmutnoncodelgliomas AT verhaakroelgw hemizygouscdkn2adeletionconfersworsesurvivaloutcomesinidhmutnoncodelgliomas |